Turesheva A,Aimagambetova G,Ukybassova T,Marat A,Kanabekova P,Kaldygulova L .2023 .Recurrent pregnancy loss etiology, risk factors, diagnosis, and management. Fresh look into a full box. J Clin Med, 10(12) : 4074.
Li Q,Chen S,Dong X,Fu S,Zhang T,Zheng W .2023 .The progress of research on genetic factors of recurrent pregnancy loss. Genet Res (Camb), 10 : .
Tomkiewicz J,Darmochwal-Kolarz D. .2023 .The diagnostics and treatment of recurrent pregnancy loss. J Clin Med, 10(14) : 4768.
Deng T,Liao X,Zhu S. .2022 .Recent advances in treatment of recurrent spontaneous abortion. Obstet Gynecol Surv, 10(6) : 355-66.
Awolumate OJ,Kang A,Khokale R,Cancarevic I. .2020 .Role of low molecular weight heparin in the management of unexplained recurrent pregnancy loss: A review of literature. Cureus, 10(10) : .
Kornacki J,Gutaj P,Kalantarova A,Sibiak R,Jankowski M,Wender-Ozegowska E .2021 .Endothelial dysfunction in pregnancy complications. Biomedicines, 10(12) : 1756.
Sah AK,Shrestha N,Joshi P,Lakha R,Shrestha S,Sharma L .2018 .Association of parental methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism in couples with unexplained recurrent pregnancy loss. BMC Res Notes, 10(1) : 233.
Banik N,Yang SB,Kang TB,Lim JH,Park J .2021 .Heparin and its derivatives: Challenges and advances in therapeutic biomolecules. Int J Mol Sci, 10(19) : 10524.
Bai W,Zhang X,Sun S,Wang Q,Li C .2021 .E ect of low-molecular-weight heparins on anti-Xa peak levels and adverse reactions in Chinese patients with recurrent spontaneous abortion: A single-centre, observational study. BMC Pregnancy Childbirth, 10(1) : 683.
Green D,Hirsh J,Heit J,Prins M,Davidson B,Lensing AW .1994 .Low molecular weight heparin: A critical analysis of clinical trials. Pharmacol Rev, 46(1) : 89-109.
Shute JK .2023 .low molecular weight heparin, and nonanticoagulant derivatives for the treatment of in ammatory lung disease. Pharmaceuticals (Basel), 10(4) : 584.
Khan ES,Basharat A,Jamil M,Ayub S,Khan MA .2017 .Preventive role of low-molecular-weight heparin in unexplained recurrent pregnancy loss. South Afr J Obstet Gynecol, 23(1) : 17-9.
Yuksel H,Kayatas S,Boza AT,Api M,Ertekin AA,Cam C .2014 .Low molecular weight heparin use in unexplained recurrent miscarriage. Pak J Med Sci, 10(6) : 1232-7.
Abbattista M,Capecchi M,Gianniello F,Artoni A,Bucciarelli P,Ciavarella A .2023 .A retrospective study on the use of low- molecular-weight heparin for prevention of pregnancy-related recurrent venous thromboembolism and obstetrical complications. Blood Coagul Fibrinolysis, 10(2) : 111-7.
Zhao L,Bi S,Fu J,Qi L,Li L,Fu Y .2021 .Retrospective analysis of fondaparinux and low-molecular-weight heparin in the treatment of women with recurrent spontaneous abortion. Front Endocrinol (Lausanne), 717630 : 717630.
Mantha S,Bauer KA,Zwicker JI .2009 .Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: A systematic review. J Thromb Haemost, 03687(2) : 7836-8.
Clark P,Walker ID,Langhorne P,Crichton L,Thomson A,Greaves M .2010 .SPIN (Scottish Pregnancy Intervention) study: A multicentre, randomised controlled trial of lowmolecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. -01-267252., 10(21) : 4162-7.
Kaandorp SP,Goddijn M,van der Post JA,Hutten BA,Verhoeve HR,Hamulyak K .2010 .Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med, 10(17) : 1586-96.
Schleussner E,Kamin G,Seliger G,Rogenhofer N,Ebner S,Toth B .2015 .Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: A multicentre trial with a minimization randomization scheme. Ann Intern Med, 10(9) : 601-9.
Arachchillage DJ,Kitchen S. Pleiotropic .2024 .e ects of heparin and its monitoring in the clinical practice. Semin Thromb Hemost, 10(8) : 1153-62.
.2018 .ACOG practice bulletin no. 196: Thromboembolism in pregnancy. Obstet Gynecol, 10(1) : 000000000-0002706.